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INTRODUCTION 
The winter issue of the MCV QUARTERLY 
presents a departure from our usual symposium pro-
ceedings. We offer, instead, five full-length articles 
and two case reports that range from respiratory 
fai lure and the dental health of pre-Columbian 
Peruvians to a report of a rare clinical entity, an 
intrapulmonary lymph node presenting as a 'coin' 
lesion. We hope that our readers will find these 
papers interesting and informative. 
THE EDITORS 
Respiratory Therapy Modalities in the 
Treatment of Acute Respiratory Failure 
JAMES A. L. MATHERS, JR., M.D. 
Assistant Professor of Medicine and Co-M edicaf Director, Respiratory Therapy, Medical College of Virginia, 
Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia 
Rapid advances have been made in the field of 
respiratory therapy in the past several years, resulting 
in an increasing sophistication and range of appli-
cation . Properly applied, these modalities have led to 
significantly increased survival in patients with acute 
respiratory failure and a decreased morbidity among 
individuals with chronic pulmonary insufficiency . It 
is the purpose of this article to put into perspective 
respiratory therapy techniques and their application 
in the treatment of acute respiratory failure. To this 
end, we may divide respiratory therapy into five cate-
gories: I) oxygen delivery, 2) airway hygiene, 3) ex-
pansion therapy (lung inflation), 4) artificial airways, 
and 5) mechanical ventilation. 
While the symptoms are not specific, the onset of 
acute respiratory failure is not a subtle event. Abnor-
mal arterial blood gases are invariably present. In-
deed, the entity is usually defined in terms of the 
degree of alteration in the arterial blood gases. Acute 
respiratory failure results from one of three general 
abnormalities: I) neuromuscular dysfunction, 2) in-
creased airway resistance, and 3) reduction of pul-
monary compliance. In pure form each of these cate-
gories produces a predictable pattern of arterial 
blood gas derangement. Rational management of 
acute respiratory failure requires an awareness of 
these alterations so that the respiratory therapy may 
This is a review of respiratory therapy modalities as they are 
currently used a t the Medica l College of Virginia . 
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be intelligently applied to stabilize or reverse the pa-
tient's pulmonary deterioration. 
In the initial assessment of the patient in acute 
respiratory distress, it is important to determine the 
nature of the respiratory compromise. Patients with 
neuromuscular dysfunction such as occurs with drug 
overdose or Guillain-Barre syndrome may have nor-
mal lungs but do not have the ability to maintain an 
adequate minute ventilation . The arterial blood gas 
derangement consists of hypoxemia and relatively 
acute hypercarbia with a normal alveolar-arterial ox-
ygen tension gradient. Respiratory failure due to a 
sudden increase in airway resistance includes entities 
such as status asthmaticus, or bronchospasm with 
retained secretions in patients with underlying 
chronic airway disease. The arterial blood gas analy-
sis will reveal hypoxemia with hypercarbia and a 
widened alveolar-arterial oxygen tension gradient. 
The functional residual capacity is elevated and, in 
many patients, there is actually an increase in pul-
monary compliance. The gas exchange abnormality 
results from ventilation-perfusion mismatching. Pa-
tients whose respiratory failure results from an acute 
loss of pulmonary compliance are those with an over-
whelming parenchymal insult such as occurs with 
extensive bacterial pneumonia, aspiration, or a sys-
temic process such as pancreatitis. These disorders 
may be grouped under the heading of adult respi-
ratory distress syndrome. The physiologic alterations 
are hypoxemia with hypocarbia and respiratory alka-
losis because of right-to-left shunting of blood, a fall 
in the pulmonary compliance, and a marked reduc-
tion in the functional residual capacity . 
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Hypoxemic Hypercapneic Respiratory Failure with 
Normal A-a 0 2 Gradient 
The Respiratory Therapy Department of an in-
stitution becomes involved with these patients when 
the decision has been made to institute mechanical 
ventilation. While the initial selection of artificial air-
ways is not in the domain of this department, usually 
it is the respiratory therapists who are called upon 
when these airways do not function properly. Be-
cause of the experience gained in managing airway 
problems, we at the Medical College of Virginia have 
developed a number of recommendations for this 
aspect of respiratory care. When selecting an artificial 
airway, one must make an initial decision between 
"compliant" and "stiff" cuffs. We prefer to use the 
large volume compliant cuff tubes because a seal is 
obtained at a lower cuff pressure. Furthermore, the 
intracuff pressure measured by the respiratory thera-
pist is a more accurate assessment of pressure exerted 
against the tracheal wall than pressures obtained 
from stiff cuffs. 
While orotracheal tubes may be rapidly inserted 
during an emergency such as a drug overdose, these 
tubes are associated with the highest incidence of 
tracheal damage since they are difficult to stabilize 
and have a tendency to move about in the trachea 
when the r:>atient is turned, m_oves or coughs. Na-
sotracheal tubes are more stable and, when a com-
pliant cuffed tube is placed via this route, they may be 
left in place for as long as two to three weeks with a 
minimum of tracheal damage. The cross-sectional 
diameter of the nasotracheal tube is smaller than the 
orotracheal tube. The combination of longer length 
and the narrow diameter may make adequate suc-
tioning difficult. Should the management of secre-
tions be a problem and a prolonged intubation antici-
pated, elective tracheostomy offers many advantages 
such as the wide variety of tubes available, including 
talking tracheostomy tubes, fenestrated tubes, and 
cuffiess tubes; patients may be fed via the oral route; 
vocal cords are not damaged; and there is no damage 
to the nasal septum. With the advent of the compliant 
cuff and better management of the artificial airway, 
the incidence of tracheal damage has decreased sig-
nificantly. It does occur from time to time, however, 
and we stress the importance of periodic monitoring 
of intracuff pressure. 
When the decision has been made to intubate 
patients with this form of respiratory failure, and the 
appropriate airway has been selected, mechanical 
ventilation is usually instituted with relative ease be· 
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cause of the normal physiology of the underlying 
lung. 
Hypoxemic Hypercapneic Respiratory Failure with 
Abnormal A-a 0 2 Gradient 
This disturbance is most frequently found in pa-
tients with increased airway resistance due to bron-
chospasm, obstructing secretions, and mucosa] swel-
ling and edema. The immediate approach to the 
hypoxemic patient is to stabilize the arterial oxygen 
tension while treating the underlying defect in hopes 
of avoiding intubation. The goal is to maintain the 
Pao2 in the range of 60 to 80 mm Hg which will insure 
hemoglobin saturation in excess of 90%. Further in-
creases in the arterial oxygen tension do not signifi-
cantly increase oxygen delivery to the tissues. The 
mode of oxygen administration is of great impor-
tance in the presence of hypercapnia. Oxygen therapy 
devices are divided into high-flow or low-flow sys-
tems. A high-flow apparatus mixes oxygen and room 
air prior to delivery to the patient. The gas flow 
delivered by the device is sufficient to provide the 
patient's total minute ventilation. Low-flow systems 
do not provide enough gas flow to supply the entire 
inspired atmosphere, and some part of the tidal vol-
ume will be supplied by the entrainment of room air. 
Such systems may provide any concentration of oxy-
gen from 21 % to 95%, but the fraction of inspired 
oxygen (F 10 2 ) can be altered by the patient's respi-
ratory pattern. Low-flow devices include the nasal 
cannula and mask oxygen and may be used when the 
tidal volume of the patient is between 300 and 700 cc, 
the ventilatory rate is less than 30/ min, and there is 
relatively stable ventilatory pattern with time. Be-
cause of the potential danger of excess oxygen admin-
istration, we prefer to keep the F10 2 as low as is 
consistent with adequate oxygen delivery to the tis-
sues. The unpredictability of the tidal volume and 
minute ventilation in an acutely ill patient are reasons 
why we generally recommend high-flow oxygen sys-
tems; the most commonly used of these are masks 
that work on the Venturi principle. The standard 
inspired 0 2 fractions available are 24%, 28%, 35%, 
and 40%. Humidifiers are not required with these 
masks because the major portion of inspired gas is 
room air. To supply a high flow of oxygen in excess of 
40%, special systems can be a rranged by the Respi-
ratory Therapy Department. 
The importance of the mucociliary escalator in 
maintaining airway homeostasis is often under-
estimated. If the mucous blanket becomes dry or 
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abnormally thick, secretions . will not mobilize nor-
mally and cough will become ineffective, leading to 
dramatic increases in airway resistance. The most 
effective means of reestablishing the mucous blanket 
is to hydrate the tracheobronchial tree. Water may be 
delivered to the airway in molecular form as humidi-
fication or in particulate form as an aerosol. Simple 
bubble-type humidifiers are sufficient for patients 
with an intact upper airway. Should the nasopharynx 
be bypassed by an artificial airway, a heater is added 
to the humidifier to further increase water content. If 
one wishes to deliver particulate water or medications 
to aid bronchial hygiene, a nebulizing device should 
be used. Ultrasonic nebulizers produce a very heavy 
water mist with uniform particle size on the order of 
.5µ, to 3µ,. Jet nebulizers, which operate on the Ber-
noulli principle, may be used for aerosolization of 
both water and medications. Droplets are propelled 
against baffles which eliminate the larger and heavier 
particles since droplets of greater than IOµ, in size are 
clinically useless as they dci not deposit in the 
tracheobronchial tree. Aerosolized medications in-
clude mucolytics, bronchodilators, vasoconstrictors, 
and steroids. In addition to instillation of water into 
the airway, efforts have been made to change the 
viscosity of the secretions by nebulizing sodium bi-
carbonate or acetylcysteine. Usually these agents are 
no better at mobilizing dried secretions than good 
hydration; however, in circumstances where the 
mucous is abnormal, such as cystic fibrosis, they may 
be useful. They may also be successfully used in those 
patients where active oral or intravenous hydration is 
not practical or safe. Inhaled bronchodilators exert 
their effect following absorption into the circulation. 
Absorption from the pulmonary system is rapid and 
the degree of bronchodilation obtained will be equal 
to that of an intravenous dose with similar blood 
levels. Vasoconstrictors may be administered by 
aerosol primarily for their topical properties. Many 
acute pulmonary diseases a re accompanied by an 
inflammatory reaction of the respiratory mucosa 
which includes profound capillary congestion and 
swelling. Topical application of a vasoconstrictor 
may have dramatic effects in decreasing the hyper-
emia and increasing lumen size. Racemic epinephrine 
is a very effective topical vasoconstrictor and a mild 
systemic bronchodilator. It may be of significant ben-
efit as adjunctive t~erapy to intravenous theo-
phylline. Choice of nebulizing devices for any of these 
medications should be made by assessing the pa-
tient's clinical status and the ability of the patient to 
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generate adequate tidal volumes. We prefer that a 
hand-held nebulizer be used since these devices are 
inexpensive and are powered from a readily available 
compressed air source. There is evidence of improved 
distribution of particles when spontaneous in-
spiration is used with these nebulizers in contrast to 
medication delivered via intermittent positive pres-
sure breathing (I PPB). These attempts at reducing 
airway resistance may be applied in conjunction with 
"expansion" therapy. Incentive spirometry appears 
to be superior to IPPB for preventing and treating 
atelectasis . 
Despite the above measures (controlled oxygen 
administration, aerosolized medications, aggressive 
management of secretions, and expansion therapy) a 
number of patients with acute respiratory failure due 
to increased airway resistance will require intubation 
and mechanical ventilation. A volume-cycled ventila-
tor is the modality of choice in acute respiratory 
failure. We follow the usual guidelines of 15 cc tidal 
volume/ kg of body weight, respiratory rate of 15 
times per minute and F 10 2 of 40% for initial setting. 
Twenty minutes to a half hour after beginning me-
chanical ventilation, the arterial blood gases are re-
peated and adjustments are made as necessary. Be-
cause the basic problem with these patients is varying 
degrees o f a irway resistance in different areas of the 
lung, it is advisable to use as low an inspiratory flow 
rate as is consistent with the patient's ventilatory 
pattern . This promotes gas delivery to poorly venti-
lated regions rather than over-expansion of well-ven-
tilated regions. It is also important to provide for 
sufficient expiratory time. If too short a period is 
allowed for expiration, hyperinflation of the patient's 
lungs beca use of gas trapping may result. A most 
useful r.ecent addition to our therapeutic techniques is 
intermittent mandatory ventilation (IMV). A circuit 
of constant gas flow is added in parallel to the pa-
tient's ventilator allowing the patient to breathe 
spontaneously at his or her own tidal volume between 
pre-set breaths delivered by the volume ventilator. 
This system minimizes the possibility of excessive 
mechanical ventilation and allows better acid-base 
control. As the patient's clinical condition improves, 
the respirator rate may be gradually reduced, pro-
moting a smoother weaning period . Complications 
that may develop in patients on ventilators include 
atelectasis in poorly ventilated areas, pneumot)lorax, 
superinfection, or drying of secretions with mucous 
plugging if the inspired atmosphere is not properly 
humidified. 
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Hypoxemic Hypocapneic Respiratory Failure 
This blood gas pattern is found in syndromes in 
which the pulmonary parenchyma has been dam-
aged. The severity of the condition will be apparent 
when there is a minimal increase in arterial oxygen 
tension in response. to an F10 2 of .4 or above. This 
documents the presence of right-to-left shunting of 
blood. The reduction of parenchymal compliance in 
these patients makes the selection of tidal volumes 
more complex than in those with obstructive prob-
lems. The pressure volume curve of the respiratory 
system may be determined at the time the patient is 
placed on mechanical ventilation. We are often able 
to identify a point in the curve above which a slight 
increase in tidal volume produces a dramatic increase 
in intrathoracic pressure. This may occur at a tidal 
volume as low as .7 liters. If one arbitrarily applies 
the rule of 15 cc/ kg to these patients, the thoracic 
capacity may be exceeded and there will be an in-
appropriately high intrathoracic pressure relative tp 
the effective tidal volume. An appropriate minute 
ventilation may be delivered by reducing the tidal 
volume and increasing the rate of ventilation. This 
will reduce mean intrathoracic pressure and reduce 
the incidence of barotrauma. 
Most patients in this category who are gravely ill 
will remain hypoxemic despite the increased F10 2 
and mechanical ventilation. These modalities do not 
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reverse the primary defect of reduced Functional Re-
sidual Capacity. This problem may be partially cor-
rected by increasing the distending pressure within 
the thorax. This is done by applying positive end 
expiratory pressure (PEEP): Com'plications include a 
reduction in cardiac output and pneumothorax. ·It 
should be noted, however, that the occurrence of 
pneumothorax is related to the level of mean intra-
thoracic pressure during mechanical ventilation and 
not to the presence or absence of PEEP. 
In . summary, respiratory therapy should be 
thought of as a series of specific steps designed to 
treat the anatomic and physiologic alterations that 
occur with the various forms of respiratory failure, 
The scientific basis of the field is rapidly advancing as 
more is learned about the mechanisms of pulmonary 
disease. Respiratory therapy should no longer be 
equated solely with IPPB but should be regarded as a 
field encompassing a number of effective treatment 
modalities. 
Suggestions for further reading 
I. BURTON GG, GEE GN, HODGKIN JE: Respiratory Care: A guide 
to Clinical Practice. New York'. JB Lippincott Company, 1977. 
2. HEDLEY-WHITE J, BURGESS GE, F EELEY TW, ET AL: Applied 
Physiology of Respirqtory Care. Boston, Little, Brown and 
Company, 1976. 
Screening Pulmonary Function Tests 
GEORGE W. BURKE, III, M.D. 
Assistant Professor of Medicine, and Director, Pulmonary Function Laboratories, Medical College of Virginia, 
Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia 
The role of the Pulmonary Function Laboratory 
has been expanded in recent years by the commercial 
development and marketing of equipment capable of 
measuring accurately and easily static lung volumes, 
diffusing capacity, and arterial blood gases. These 
sophisticated measurements, which were once the 
purview of research physiologists, are now readily 
attainable as screening measurements in most com-
m unity hospitals. This review is intended not as a 
summary of the entire field or as a technical guide for 
performance of pulmonary function tests but as a 
survey of some clinical applications and pitfalls of 
screening tests and a statement of guidelines for their 
use. It is assumed that the reader already has some 
experience in ordering and interpreting routine spiro-
grams and arterial blood gases. 
Pulmonary function tests are intended to answer 
four questions: 
1) Is the patient restricted? 
2) Is the patient obstructed? 
3) Does the patient have abnormalities of gas 
exchange? 
4) Are the observed abnormalities compatible 
with the patient's symptoms and clinical di-
agnosis? 
Restriction is a reduction of total lung capacity 
or one of its subvolumes (Fig I) as a result of collapse 
or volume displacement of the lung (fibrothorax), in-
creased elastic recoil of the lungs (pulmonary fibro-
sis), increased elastic recoil of the rib cage or abdo-
men (obesity), or loss of forces needed to overcome 
normal elastic recoil (muscular dystrophy) . It is im-
Correspondence and reprint requests to Dr. George W. 
Burke, III, Box 903, Medical College of Virginia, Richmond, VA 
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portant to realize that a routine spirometric vital 
capacity measurement may not adequately describe 
the presence or degree of restriction. For example, 
some patients with advanced emphysema may have 
reduced vital capacity in the face of a large residual 
volume, with increased total lung capacity caused by 
obstructive air trapping; it is misleading to label such 
patients as "restricted" on the basis of reduced vital 
capacity when, in fact, they are overinflated. On the 
other hand, true early restriction may occur in the 
face of normal vital capacity. An example of this is 
obesity, a condition in which the abdominal mass 
renders the chest wall less compliant by hindering 
downward displacement of the diaphragm. The 
earliest change in the restrictive pattern of obesity is a 
marked reduction in expiratory reserve volume 
(ERV) (see Fig I) but only minor alterat.ions of the 
total lung and vital capacities. Therefore, accurate 
evaluation of patients with suspected restrictive dis-
orders should include, in addition to routine spirome-
try, a measurement of total lung capacity and its 
subdivisions by inert gas or plethysmographic tech-
niques. The following case illustrates the use of pul-
monary function studies in following the course of a 
restrictive lung disorder: 
Case I. A 53-year-old white woman developed exertional 
dyspnea and cough in 1971. A chest roentgenogram re-
vealed bilateral basilar "ground-glass" opacities. In April 
1972, an open lung biopsy showed desquamative interstitial 
pneumonia. She was placed on 20 mg prednisone daily in 
August 1972, and sequential pulmonary function tests were 
performed (Table I). The initial vital and total lung capaci-
ties were consistent with moderately severe restriction, and 
there was a correspondingly severe reduction in diffusing 
capacity. After two years of prednisone therapy, these ab-
normalities improved substantially (October 1974). When 
steroids were stopped she experienced a severe relapse 
163 
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(February 1976) which was reversed by their resumption 
(February 1977). In 1977 she was in remission while taking 
20 mg prednisone on alternate days .. The pulmonary func-
tion studies provided quantitative objective evidence that a 
prolonged course of steroid therapy was necessary. 
Obstructive impairment, defined as a reduction 
in inspiratory or expiratory air-flow rates, is a result 
of intrinsic airway disease or loss of lung elastic re-
coil. The latter causes airways to lose their structural 
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Fig 1-Spirogram with various subdivisions of total lung capacity. 
Initial deflections at left are tidal volumes recorded on slowly 
moving recording paper. Large deflection upward is inspiration to 
total lung capacity, followed by expiration to residual volume and 
resumption of tidal breathing. Residual volume is not measured 
directly, but has been previously determined by inert gas study. 
Time is on the horizontal axis, volume on the vertical. 
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support. Intrinsic airway disease may be caused by a 
variety of conditions ranging from totally reversible 
asthmatic bronchoconstriction to irreversible ad-
vanced chronic bronchitis with bronchiolitis obliter-
ans. Loss of elastic recoil almost always is a result of 
localized or generalized emphysema. 
Because the conditions causing airways obstruc-
tion tend to become more exaggerated during forced 
expiration (during which alveoli and airways are rap-
idly diminishing in both length and diameter), the 
conventional method of assessing obstructive impair-
ment is by measuring averaged flow rates on a vol-
ume-time curve of an ordinary spirogram during a 
maximally forced expiration of the vital capacity. 
(Fig 2). Although one could arbitrarily measure flow 
at a multitude of points on the curve, three measure-
ments have been standardized and used most fre-
quently (see Fig 2): the timed vital capacity (FEY,); 
the ratio of FEY, to total vital capacity; and the 
maximum mid-expiratory flow rate (MMEF) (the av-
eraged flow over the mid-half of the vital capacity). 
Ordinarily all three measurements are made and ab-
normalities of one tend to correlate with those of the 
others. Additional measurements such as peak flow, 
total expiratory time, and forced expiratory volume 
in three seconds, or "FEY3," add little new informa-
tion but may be sensitive indicators of changes wheri. 
evaluating drug effects in population samples. 
Obstruction is conventionally quantitated dur-
ing expiration; however, patients develop dyspnea 
from obstructive impairment because of the increased 
work of breathing during inspiration. In most cases, 
obstruction during inspiration is inferred by abnor-
malities in the FEY, and MMEF; unfortunately, 
there are several important exceptions to this. Indi-
viduals with obstruction isolated to the trachea or 
larynx (for example, tracheomalacia following endo-
tracheal intubation) may not have evidence of ex-
TABLE 1 
Sequential Function Studies in a Patient with Desquamative 
Interstitial Pneumonia. 
August October February February Pre-
1972 1974 1976 1977 dieted 
Vital capacity, 
liters 2.06 3.45 2.30 3.12 3.97 
Total lung 
capacity, 
liters 3.55 5.24 3.79 4.95 6.32 
Arterial Po,, 
torr 66 73 67 76 90 
Diffusing capacity, 
ml/ min/ torr 8.5 17.0 7.9 11 .2 22.0 
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Fig 2-Forced vital capacity shown on rapidly moving recording 
paper. Total downward excursion of curve (vertical axis) is vital 
capacity. Volume exhaled during the first second is FEY,. MMEF 
is slope of line connecting points A and B. Time is on the horizon-
tal axis. 
piratory obstruction if their defect is above the tho-
racic outlet, or they may have spirometric 
abnormalities which are misinterpreted as general-
ized airways obstruction if their defect is below the 
thoracic outlet. In addition, individuals with sub-
stantial narrowing of bronchioles but normal patency 
of bronchi (for example, young smokers with early 
chronic bronchitis) may have completely normal 
spirometric flow rates but isolated abnormalities of 
MM EF which are difficult to interpret because of the 
large standard deviation of this test in the normal 
population. 
When either of these exceptions is suspected, 
additiona l information may be obtained by a record-
ing of a flow-volume curve, or graphical representa-
tion of instantaneous mouth flow and expired volume 
during a forced inspiration and expiration of the vital 
capacity (Fig 3 ). The normal configuration of this 
curve is shown in Figure 3a. Fixed obstruction in the 
trachea produces a characteristic fixed limitation to 
flow which is independent of volume (Fig 3b ). An 
additional advantage of the flow-volume curve is its 
depiction of inspiratory events, thus facilitating the 
detection of variable extrathoracic upper-airway ob-
struction (Fig 3c ). Generalized bronchiolar narrow-
ing produces flow limitations which are detectable 
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Fig 3a-I nspiratory-expiratory flow-volume curve shows normal 
configuration in a 28-year-old man . 
Fig 3b-Fixed upper-airway obstruction seen in a 32-year-old man 
with stenosis of intrathoracic trachea. 
Fig Jc-Curve shows variable extrathoracic obstruction as a result 
of loss of cartilagenous tracheal support in the subglottic region. 
The weakened area collapses on inspiration but is distended during 
expiration by positive airway pressure. 
Fig 3d-"I nwardly concave" distortion of the expired curve at 
lower lung volumes is seen in a 30-year-old chronic cigarette 
smoker with a normal spirograni. The distortion is due to 
bronchiolar obstruction. 
only on expiration at lower lung volumes and tend to 
worsen as volume diminishes. This will result in an 
"inwardly concave" appearance to the flow-volume 
curve in patients with obstruction limited to the bron-
chioles (Fig 3d). It should be pointed out that this 
"inwardly concave" configuration is not specific for 
peripheral small airways obstruction; if the spiro-
gram also indicates obstruction, the curve is not use-
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fut for differentiating generalized obstruction from 
that isolated to peripheral airways. The following 
case is an example of obstructive impairment and 
also illustrates the value of lung volume determina-
tions by the helium dilutional method in differentia-
ting obstructive from restrictive impairment: 
Case 2. A 19-year-old male gas station attendant abruptly 
developed exertional dyspnea in January 1976. Seven 
months later a carefully taken history revealed that he had 
been caring for his brother's homing pigeons since late 
December 1975. The ·chest roentgenogram was normal , 
although symptoms persisted. Pulmonary function studies 
(Table 2, July 1976) revealed a reduced vital capacity; 
however, the total lung capacity and residual volume sug-
gested probable obstructive air trapping rather than restric-
tion. The FEV1 and MMEF confirmed obstruction. With-
out specific treatment other than ceasing the pigeon 
exposure, his symptoms resolved and objective improvement 
was evident on sequential studies (September 1976). Al-
though both restriction and obstruction may occur in a ller-
gic alveolitis, restriction is usually the dominant impair-
ment. However, in this patient 's case, obstruction occurred 
without restriction. 
Arterial hypoxemia is a sequela of impaired gas 
exchange; however, measurement of resting arterial 
oxygen tension (Po2) alone may not be sufficiently 
sensitive to detect such impairment. Impaired gas 
exchange is also present if there is an increase in the 
observed oxygen tension difference between alveolar 
air and arterial blood (DA-a 0 2) or if there is an 
abnormality in the diffusing capacity for carbon 
monoxide. For ambulatory patients breathing room 
air, DA-a 0 2 can be estimated by obtaining a sample 
of arterial blood under steady-state conditions. Al-
veolar oxygen tension is calculated by the standard 
alveolar air equation: 
PA02 = F102(713) = Paco2 (F10 2+ 1 -;0°2) 
F102 = fraction of02 in inspired air 
Paco2 arterial Pco2 (identical to mean alveolar 
Pco2) 
RQ = respiratory quotient 
The achievement of steady-state conditions is an es-
sential prerequisite for this test because the estima-
tion of alveolar oxygen tension is based on the as-
sumption that the ratio of C02 produced to 0 2 
consumed (RQ) is 0.8. Transient hyperventilation 
caused by anxiety or pain will invalidate this assump-
tion. Direct measurement of RQ may provide a more 
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TABLE 2 
Sequential Function Studies in a Patient with Allergic Alveol-
itis Due to Pigeon Exposure. 
July September 
1976 1976 Predicted 
Vital capacity, 
liters 3.98 4.42 5.62 
Total lung 
capacity, liters 6.95 6.68 7.34 
Residual volume, 
liters 2.97 2.26 1.72 
FEY,, liters 2.51 3.09 4.54 
FEV 1/ Vital 
Capacity,% 63 70 80 
MMEF, liters/sec. 1.24 2.03 4.90 
refined estimation of PA 0 2; however, this also re-
quires sampling under steady-state conditions. For 
either approach, hyperventilation may be avoided by 
inserting an arterial cannula and allowing the patient 
to rest prior to sample collection. 
The measurement of carbon monoxide diffusing 
capacity by the simplified single-breath technique re-
quires the patient to breath hold at total lung capacity 
for ten seconds. Patients who are markedly dyspneic 
at rest may not be able to perform this test. Despite 
these limitations, useful results are forthcoming for 
most cooperative subjects. 
The precise pathophysiologic explanation for 
impaired diffusion of carbon monoxide in lung dis-
eases is unknown. Most authorities agree that it is a 
sign of alveolar or capillary destruction. Therefore, 
impaired CO uptake may occur in parenchymal de-
structive processes such as idiopathic fibrosing al-
veolitis, scleroderma, advanced sarcoidosis, and in 
vascular obliterative processes such as idiopathic pul-
monary hypertension or multiple small pulmonary 
emboli. It is also impaired in processes causing re-
versible loss of functioning alveoli, examples of which 
are bacterial pneumonia and alveolar proteinosis. CO 
uptake is impaired in generalized emphysema due to 
emphysematous destruction of alveoli but remains. 
nearly normal in chronic bronchitis because the de-
structive process is confined to airways and centri-
lobular elements of the parenchyma. Diffusing capac-
ity may be spuriously impaired by several conditions. 
The first is the presence of severe anemia, which 
limits the availability of hemoglobin CO receptors; 
the second is that failure to achieve true total lung 
capacity during the breathhold will reduce CO up-
take in proportion to the reduction in potential lung 
volume. The following case illustrates the value of the 
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TABLE 3 
Pulmonary Function Studies in a Patient with Sarcoidosis 
0 2 were also normal. However, a moderately severe reduc-
tion in diffusing capacity suggested the presence of wide-
spread interstitial disease despite the clear roentgenographic 
lung fields. Hemoglobin was normal. A transbronchoscopic 
lung biopsy showed interstitial non-caseating granulomata 
consistent with sarcoidosis. 
September 1978 Predicted 
Vital capacity, liters 2.98 3.63 
FEY" liters 2.68 2.88 
FEY/vital 
capacity,% 90 79 
MMEF, 
liters/second 4.03 3.37 
Total lung capacity, 
liters 3.85 5.12 
Residual volume, 
liters .76 1.49 
Pao,, torr 92 90 
DA-a 0 2 , torr 13 15 
Diffusing capacity, 
ml/ min/ torr 12.0 21.7 
diffusing capacity in screening patients for the pres-
ence of gas exchange impairment: 
Although measured impairment in pulmonary 
function frequently provides an objective explanation 
for the presence of dyspnea, many patients may expe-
rience this symptom because of abnormalities which 
are undetectable on screening evaluations. Negative 
screening studies should stimulate a careful search for 
vascular disease or nonpulmonary causes of dyspnea. 
For example, "metabolically justified" hyperpnea 
and dyspnea may accompany hyperthyroidism; pa-
tients with mitral stenosis or early congestive heart 
failure may have only mild impairment in lung me-
chanics despite severe exertional dyspnea; and pa-
tients with partial obliteration of the pulmonary vas-
culature may have normal lung mechanics, arterial 
oxygen tensions, and diffusing capacities while at 
rest, only to show abnormalities during exercise. 
Cas~ 3. A 32-year-old woman complained of mild ex-
ertional dyspnea of two months duration. Chest roentgeno-
gram revealed bilateral hilar adenopathy. Pulmonary func-
tion studies (Table 3) showed a modest reduction in total 
lung capacity (75% predicted) with normal vital capacity 
anq flow rates. Resting arterial oxygen tension and DA-a 
For a variety of vascular and interstitial pul-
monary disorders, it may be appropriate to evaluate 
TABLE 4 
Guidelines for Ordering Medical or Surgical Screening Pulmonary Function Studies. 
1. Asymptomatic non-smoker 
2. Asymptomatic smoker 
3. Heavy smoker with dyspnea and/ or chronic bron-
chitis 
4. Young asthmatic 
5. "Old" asthmatic (> 30 years) 
6. Suspected tracheal obstruction, stridor, or unex-
plained obstruction on a previous spirogram 
7. Suspected interstitial lung disease 
8. Suspected pulmonary vascular disease 
9. Suspected a natomic right-to-left shunt 
10. Suspected early small-airways disease 
No studies; " routine spirogram" (vital capacity, FEY" MMEF) if thoracic 
surgery is planned. 
Routine spirogram; add resting arterial blood gases if thoracic surgery is 
planned. 
Routine spirogram; total lung capacity; diffusing capacity; resting arterial 
blood gases. 
Spirogram before and after an inha led bronchodilator. 
Spirogram before and after inhaled bronchodilator; tota l lung capacity: resting 
arterial blood gases. 
lnspiratory and expiratory flow-volume curve. 
Spirogram; total lung capacity; diffusing capacity; steady-state arteria l blood 
gases with DA-a 0 2 • 
Same as #7. Add exercise DA-a 0 2, physiologic deadspace, end tidal CO, 
gradient. 
Arterial blood gases while breathing I 00% 0,. This study should never be 
requested for patients with emphysema or chronic bronchitis who have CO, 
retention. 
In view of the limited clinical benefits, adequate evaluation is too expensive. 
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physiology during exercise as resting abnormalities 
frequently are exaggerated during exercise. However, 
pulmonary exercise testing, unlike cardiac stress test-
ing, should provide a graded low level of exercise 
(doubling or tripling of the oxygen uptake) rather 
than maximum stress. In fact, recent experimental 
evidence' has suggested that maximum stress mea-
surements are potentially misleading because normal 
subjects may demonstrate transient abnormalities in 
Pao2 and DA-a 0 2 while performing temporary but 
severe tasks such as rapid stair-climbing. Although a 
complete discussion of exercise physiology testing is 
beyond the scope of this paper, som'e recent reviews 
of the relevance of pulmonary exercise testing in clini-
cal medicine are included in the bibliography.1-2 
Table 4 is a suggested modus operandi for order-
ing screening pulmonary function studies for specific 
problems. Physicians ordering such tests must realize 
that measurements of lung mechanics require both 
cooperation ard effort. Too much testing at a sing!~ 
sitting may fatigue the patient and cause spuriously 
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abnormal results. For example, it would be unwise to 
subject a patient to both screening studies and exer-
cise physiology studies for suspected vascular disease 
on the same day. Therefore, in the context of the 
suggestions in Table 4, clinical wisdom and common 
sense should dictate which tests are appropriate for 
individual patients. · 
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Flexible Fiberoptic Bronchoscopy 
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The flexible fiberoptic bronchoscope was in-
troduced in Japan by Dr. Shigeto Ikeda in the mid-
I 960s and became available .for clinical use in the 
United States around i 970. The application of this 
technique represents one of the most significant ad-
vances for the diagnosis and management of chest 
diseases as it enables the physician to directly visual-
ize the tracheobronchial tree and obtain diagnostiC 
specimens from regions of the lung previously in-
accessible to the rigid bronchoscope. Except for sub-
pleural lesions, fiberoptic bronchoscopy is the surgi-
cal procedure of choice in the evaluation of many 
pulmonary lesions.' In addition, fiberoptic bron-
choscopy plays a major therapeutic role in the evalu-
ation of airway patency and elimination of retained 
secretions. 
The new Olympus® (BF-IT), Machida® (FBS-
6TL; FBS-6TL II), and Pen tax® (FB- I 9A) fiberoptic 
bronchoscopes have larger channels measuring 2.6 
mm in diameter as compared with older inodels 
whose channels measure 1.8 to 2.2 mm. These larger 
channels provide more effective suctioning and larger 
biopsy specimens.2 
Indications for Fiberoptic Bronchoscopy 
The following are accepted indications for fiber-
optic bronchoscopy: 
1. Any pulmonary lesion of uncertain nature. 
Subpleural lesions are exceptions. 
2. Retained bronchial secretions 
3. Evaluation of airway patency 
4. Miscellaneous: 
a. hemoptysis in a patient with a normal 
chest radiograph 
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b. positive sputum cytology (that is, cancer) 
in a patient with normal chest radiograph 
c. small, peripheral foreign bodies in adults 
d. patients with trauma or disease affecting 
the cervical spine or jaw 
e. patients on mechanical ventilators 
Rigid bronchoscopy is preferred in the following 
situations: 
I . Severe pulmonary hemorrhage 
2. Centrally located foreign bodies 
3. Children requiring bronchoscopy 
4. Tracheal stenosis, secondary to intrinsic or 
extrinsic lesions 
Risks and Contraindications 
The following conditions are associated with in-
creased risks during or following fiberoptic bron-
choscopy:3 
I. Hemoptysis (increased incidence of post-
bronchoscopy bleeding) 
2. Bronchial asthma (danger of severe bron-
chospasm) 
3. Uremia (danger of severe hemorrhage after 
biopsy) 
4. Immunosuppression (hazard of post-bron-
choscopy infection) 
5. Superior vena cava obstruction (danger of 
inducing laryngeal edema) 
Poor patient cooperation, hypoxemia with an 
arterial Po2 that cannot be increased to 60 to 65 torr 
with supplemental oxygen, uncorrected bleeding dia-
thesis, acute respiratory acidosis of any degree, dan-
gerous cardiac arrhythmias, recent (within six weeks) 
acute myocardial infarction, and untreated active 
pulmonary tuberculosis are contraindications for fi-
beroptic bronchoscopy. Terminally ill and aged pa-
tients with unstable vital signs should not have fiber-
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optic bronchoscopy performed. Severe pulmonary 
hypertension and poor cardiopulmonary reserve are 
relative contraindications. 
Physician and Patient Preparations for Fiberoptic 
Bronchoscopy 
Prior to bronchoscopy, the endoscopist should 
perform a history and physical examination, review 
the chest radiographs, electrocardiograms, and blood 
and urine tests . Arterial blood gas and spirometric 
studies should be performed, if possible, prior to the 
procedure. Coagulation studies (prothrombin time, 
partial thromboplastin time, platelet count) should 
be obtained. Three sputum smears for acid-fast orga-
nisms shouid be obtained in patients whose chest 
radiographs are consistent with a diagnosis of tu~ 
berculosis . Finally, a signed operative permit should 
be obtained from the patient. 
Oxygen prophylaxis. All patients should receive 
supplemental ,'oxygen administered by nasal catheter 
or cannula 5 L/ min . The Pao2 may decrease as much 
as 20 torr during and for several hours after bron-
choscopy .4 This drop in oxygen tension appears to be 
the result of multiple factors, including partial or 
complete obstruction of the airways, filling of alveo-
lar spaces with lavage or anesthetic solutions, and 
suctioning. Therefore, all patients who have a re-
duced Pao2 prior to the procedure should be given 
supplemental oxygen for six to ten hours following 
bronchoscopy. 
Cardiac monitor. It is desirable that all patients 
should have cardiac monitoring during bron-
choscopy. The sudden development of an arrhythmia 
or change in cardiac rate may suggest hypoxemia. 
Recent studies suggest that fiberoptic bronchoscopy 
does not consistently enhance preexisting ectopic 
beats in patients with ischemic heart disease, there-
fore, the procedure is not contraindicated in patients 
with stable angina. However, patients with coronary 
heart disease should be monitored closely during the 
procedure, since sinus tachycardia can develop, 
which may cause ischemic events thus precipitating 
arrhythmias.• The most important factor in the devel-
opment of arrhythmias is not bronchoscopy itself, 
but rather the underlying cardiopulmonary status of 
the patient . 
Preoperative orders. For a morning procedure, 
NPO after midnight is required; for an afternoon 
procedure, only a light liquid breakfast may be given . 
Atropine 0.8 to 1.0 mg is given intramuscularly 30 
minutes before bronchoscopy since this drug blocks 
vasovagal reflexes and also reduces the amount of 
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bronchial secretions. Depending upon the age, size 
and clinical condition of the patient, morphine 7 .5 to 
15 mg or meperidine 50 to JOO mg may be given 
intramuscularly with the atropine. In our institution 
we commonly use codeine 60 mg and atropine 0.8 to 
1.0 mg 30 minutes prior to bronchoscopy. Patients 
with severely reduced pulmonary function are given 
only atropine. 
Topical anesthesia is an extremely important 
factor in securing patient acceptance and performing 
a successful bronchoscopic examination. Lidocaine is 
the most commonly used agent as it is effective and 
safe provided a maximum dosage of 600 mg is not 
exceeded during the procedure. This dose, which is 
larger than that usually recommended, has been 
found safe in a large series. In patients with severe 
liver disease or congestive heart failure no more than 
300 mg should be given. 
The patient is first instructed to gargle with ap-
proximately 4 ml of 4% lidocaine for one to two 
minutes, followed by spraying of the oropharynx and 
the most widely patent nostril with 5 ml of 4% lido-
caine via a #15 DeVilbus atomizer. Cotton balls 
soaked in 4% lidocaine are applied to each piriform 
sinus for one minute; then , via a curved cannula, 2.0 
ml of I% lidocaine is administered over the vocal 
cords. 
With the patient either seated or supine the flex~ 
ible fiberoptic bronchoscope can be passed (with or 
without an endotracheal tube) either transnasally or 
transorally . The most commonly used technique for 
diagnostic study in the United States is the direct 
transnasal passage. (If fiberoptic bronchoscopy is 
carried out through an endotracheal tube, the inter-
nal diameter of the tube should be 8.5 mm). The 
distal six inches of the fiberoptic bronchoscope is 
lubriCated with lidocaine jelly. The bronchoscope is 
then passed through the nostril and when in the 
oropharynx, the tip angulated anteriorly to view the 
larynx. If the patient begins coughing, 2 ml of 1 % 
lidocaine is administered over the vocal cords. The 
patient is instructed to take a deep breath, and the 
bronchoscope is passed into the trachea during this 
inspiration. Additional small amounts of I% lido-
caine are given as necessary to suppress coughing. 
Once the bronchoscope is in the tracheobronchial 
tree, examination of all five lobes can be performed in 
approximately 10 to 15 minutes . 
Biopsy Technique 
A variety of biopsy instruments, primarily 
brushes and forceps, are available for diagnosis of 
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pulmonary lesions. In general, both brushes and for-
ceps are used for all lesions. The brush biopsy is 
obtained by moving the brush briskly back and forth 
over the suspicious area. If the bronchoscope has 
been introduced through the endotracheal tube, after 
each biopsy, the brush is pulled back just inside the 
bronchoscope and the bronchoscope removed from 
the tracheobronchial tree. The brush is then ad-
vanced forward and smears are made on glass slides 
which are placed in 95% alcohol. 
Forceps biopsy can be used in the diagnosis of 
local or diffuse pulmonary lesions. In diffuse lung 
disease, the forceps is introduced into a small periph-
eral airway, usually in a lower lobe segment. The 
forceps is opened in inspiration, the patient is in-
structed to exhale completely, the forceps is advanced 
slowly about I cm, and at the end of an exhalation 
the biopsy obtained. Following the removal of the 
forceps, the distal end of the bronchoscope should be 
wedged into the bronchial segment for one minute to 
prevent possible bleeding. The biopsy specimen is 
placed in a sterile tube filled with Ringer solution. In 
general, three to four specimens, sometimes as many 
as six to eight, are taken . Bronchial washings with IO 
to 20 ml saline solution should also be obtained. The 
specimens should be sent for cytology, smears, a nd 
cultures for acid-fast organisms, fungi, and patho-
genic organisms. 
It is desirable to perform transbronchial biopsy 
under fluoroscopic control if available. Because of 
the possibility of bilateral pneumothorax, biopsies 
are taken from one lung only. 
In localized disease the forceps is introduced to 
the lung lesion, then withdrawn I cm, opened, then 
advanced until it touches the lesion; the forceps is 
closed and the biopsy obtained. Prior to brush or 
forceps biopsy, administration of 5 ml boluses of 
I: 20,000 epinephrine over visible tumors or into dis-
tal airways (in cases of diffuse lesions) before biopsy, 
reduces the incidence of pulmonary hemorrhage. A 
total of 20 ml of I : 20,000 epinephrine solution can be 
given over a period of 20 minutes, except in patients 
with severe hypertension and serious arrhythmias. In 
patients with uremia, brush or forceps biopsies 
should not be done because of the possibility of se-
vere hemorrhage; in those with a platelet count of less 
than 50,000/ mm,3 six to ten platelet packs should be 
infused just prior to bronchoscopy. Finally, patients 
with bronchial asthma are prone to develop severe 
bronchospasm. They should be given bronchodila-
tors and probably steroids prior to bronchoscopy. 
Where centrally located visible carcinoma of the 
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lung is present, the incidence of positive forceps 
biopsy is about 97%. The overall yield in peripheral 
carcinoma of the lung is about 60% to 70%, in meta-
static carcinoma of the lung, about 30% to 40%, and 
in diffuse lung diseases, the diagnostic yield ranges 
from 62% to 79%. In stage I sarcoidosis, trans-
bronchial biopsy will confirm the diagnosis in 50% to 
60% of cases while in stage II and stage III sarcoid-
osis, diagnostic success is about 90%. 
Complications of Fiberoptic Bronchoscopy 
The overall complication rate is approximately 
8%. The mortality rate is 0.1 %. The following are 
potential complications: 
I. Hypoxemia 
2. Laryngospasm 
3. Hemorrhage 
4. Pneumothorax 
5. Bronchospasm 
6. Cardiac arrhythmias and acute myocardial 
infarction 
7. Post-bronchoscopy infection 
8. Trauma due to endotracheal tube insertion 
9. Hypoventilation 
In summary, fiberoptic bronchoscopy is an ex-
tremely useful technique in the diagnosis and man-
agement of pulmonary diseases. It is quite safe and 
comfortable for the patient and it permits examina-
tion of airways previously inaccessible to the endo-
scopist. However, physicians must evaluate each pa-
tient carefully. The procedure should be performed 
by an experienced endoscopist who is familiar with 
risk factors and proper indications for fiberoptic 
bronchoscopy. 
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Bedside Flow-Directed Balloon 
Catheterization in the Critically Ill Patient 
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Prior to 1970, catheterization of the right heart 
and pulmonary artery required the use of fluoro-
scopic guidance and was only performed in special-
ized research units and/ or the cardiac catheterization 
laboratory. The need to assess the hemodynamic 
status of the left atrium and ventricle on a continuing 
basis brought about the development of the flow-
directed ballon-tipped catheter.' With the availability 
of this tool, routine bedside right heart catheteriza-
tion has become a. reality in the critical care units of 
many community hospitals. This technique provides 
the physician with the means for indirectly appraising 
left heart hemodynamics and to gauge the effects of 
various modes of therapy on tissue perfusion by mon-
itoring the pulmonary artery and pulmonary capil-
lary wedge pressures (PCWP), cardiac outputs, and 
mixed venous Po2 (Pvo2 ). 
Relationship Between Pulmonary Capillary Wedge 
Pressure ( PCWP) and Left Ventricular End Diastolic 
Pressure 
The term pulmonary capillary wedge pressure 
originated many years before the discovery of the 
flow-directed catheter. During routine diagnostic 
right heart catheterizations, it was customary to ad-
Correspondence and reprint requests to Mr. Eugene Millen, 
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vance the rigid catheter, under fluoroscopic guidance, 
from a large pulmonary artery to a more peripheral 
position. Here resistance was met within a small pul-
monary artery branch whose inside diameter approx-
imated that of the catheter. The catheter was then 
forcibly advanced a short distance until it became 
physically wedged. This "wedging" occluded the pul-
monary artery pressure tracing and monitored the 
distal or downstream pressure, that is, left heart pres-
sures were reflected retrograde through the pul-
monary capillaries to the catheter tip. These same 
pressures can now be monitored at the bedside, em-
ploying the flow-directed catheter by inflating the 
balloon and temporarily obstructing pulmonary ar-
tery pressures and flow. 
Since the PCWP is an indirect reflection of the 
left atrial pressure, it is used as an assessment of the 
left ventricular filling pressure during diastole. The 
value of this measurement is important in the diagno-
sis and management of the critically ill patient. 
Indications for Bedside Pulmonary Artery 
Catheterization 
Although there are no universally agreed upon, 
absolute indications for the use of the flow-directed 
catheter, the following list includes many of the clini-
cal conditions in which hemodynamic monitoring 
may be useful. 
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I. As a guide to fluid management 
a. acute renal failure 
b. acute pancreatitis 
c. burn patients 
2. Evaluation and management of shock states 
a. septic 
b. hypovolemic 
c. cardiogenic 
3. Diagnosis and management of respiratory fail-
ure 
a. adult respiratory distress syndrome 
b. primary pulmonary hypertension 
c. pulmonary embolism 
4. Diagnosis of cardiac dysfunction 
a. cardiac tamponade 
b. constrictive pericarditis 
c. mitral insufficiency 
d. intracardiac shunts (left to right) 
5. Assessment of left ventricular function 
a. acute myocardial infarction 
b. congestive heart failure 
c. post-open heart surgery 
d . ventricular afterload reduction 
Catheter Insertion 
Our choice of insertion routes are the median 
basilic, internal jugular, femoral, and subclavian 
veins, in that order. (We are particularly hesitant to 
employ the subclavian approach because of the 
chance of pneumothorax which may be poorly toler-
ated in the critically ill patient). Percutaneous guide 
wire insertion (Fig. I) is normally used, although on 
rare occasions a surgical cutdown of a median basilic 
vein may be necessary . 
Fig. I-Percutaneous catheter introducer consisting of wire guide 
(small arrow), dilator (double arrow) and sheath (large arrow). 
This assembly is used in conjunction with a 16 gauge teflon needle. 
Following introduction, the catheter tip is ad-
vanced to the intrathoracic vena cava (a distance of 
35 to 40 cm from the femoral or basilic vein and 15 to 
20 cm from the internal jugular insertion site) where 
the balloon is then inflated with from 0.5 to 1 cc of 
air. With the balloon acting as a sail, the catheter is 
pushed through the right atrium and ventricle and 
into the pulmonary artery (Fig. 2). The position of 
the catheter tip is determined by the pressure contour 
tracing monitored throughout the procedure (Fig. 3). 
As the catheter tip reaches smaller caliber pulmonary 
arteries, the balloon occludes the vessel, producing a 
wedge pressure tracing. During catheter advance-
ment, the electrocardiogram is carefully monitored 
by the nurse assisting with the procedure. The nurse 
reports the number of successive PVCs as a warning 
to the physician to change the position of the catheter 
tip. 
Hemodynamic and Physiological Indices Derived from 
Flow-directed Catheters 
Pulmonary capillary wedge pressure (PC WP). 
The PCWP reflects left ventricular end diastolic fill-
ing pressures in the absence of left atrial or mitral 
valve dysfunction (mitral stenosis, mitral in-
sufficiency, left atrial myxoma, and other conditions). 
The normal pulmonary wedge pressure ranges from 6 
to 12 mm Hg with a value greater than 12 . mm Hg, 
implying either left ventricular dysfunction or fluid 
overload. To differentiate these two clinical condi-
tions, a cardiac output and/ or Pvo2 needs to be ob-
tained. (See below) A low pu.lmonary wedge pressure, 
that is, below 6 mm Hg, implies "pure" intravascular 
fluid depletion such as occurs with hemorrhage, or 
superior 
vena cavo 
Fig. 2-Flow-directed catheter advanced from superior vena cava 
through the heart into a branch of left pulmonary artery . 
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Fig. 3-ldealized recording of pressures seen as catheter is passed from right atrium (RA), right ventricle (RV), and pulm onary a rtery 
(PA); with the balloon inflated, the pulmonary wedge pressure (PWP) is obtained . 
"relative" intravascular depletion as is seen in the 
early stages of septic shock. Once again cardiac out-
put or Pvo2 determinations will help differentiate 
these entities. (See below) 
Cardiac output. Balloon-tipped flow-directed 
catheters are available with thermodilution cardiac 
output capabilities. These triple lumen catheters have 
an orifice located 30 cm proximal from the tip 
through which room temperature or iced saline, or 
5% dextrose solutions, can be injected for the purpose 
of obtaining a cardiac output.2 A thermistor bead 
located near the tip of the catheter detects changes in 
temperature from which cardiac outputs can be com-
puted. 
Mixed venous Po2 ( Pvo2 ). The flow-directed cath-
eter also permits sampling of true mixed venous 
blood (obtained from the pulmonary artery) for Po2 
and oxygen content determinations. The Pvo2 (nor-
mal range in a nonanemic patient, 35 to 40 torr) 
reflects changes in cardiac output and tissue per-
fusion. As tissue perfusion and/ or cardiac output 
decreases, the Pvo2 decreases as peripheral tissues 
extract more oxygen from the blood. For example, a 
patient with a high PCWP and a normal or elevated 
Pvo2 has a normal or elevated cardiac output thus 
implicating fluid overload as the cause for the ele-
vated PCWP. In a patient whose PCWP is elevated 
and Pvo2 (and thus cardiac output) is low, tissue 
perfusion has been compromised due to left ventricu-
lar dysfunction. In contrast, a patient with a low 
PCWP and a low mixed Pvo2 (usually below 30 torr) 
probably has "pure" intravascular fluid depletion 
and will need intravenous fluids to correct the defi-
ciency. A low PCWP and an inappropriately elevated 
Pvo2 (usually above 30 torr) is usually a sign of sepsis. 
In this condition peripheral arteriovenous shunting 
occurs with failure to extract oxygen at the cellular 
level. 
Shunt equation ( Qs / Qt). The degree of physio-
logical and/ or anatomic shunting which occurs in 
patients with both cardiac and pulmonary disease(s) 
can be calculated by employing the standard shunt 
formula and obtaining true mixed venous oxygen 
contents from the flow-directed catheter when in the 
pulmonary artery position. The shunt calculation, 
although somewhat cumbersome and complicated, 
can be used as an index for weaning patients from 
ventilators, for determining the most appropriate 
level of positive end expiratory pressure (PEEP}, and 
for following the improvement or deterioration in the 
patient's cardiopulmonary status on a day-to-day 
basis. 
Complications 
As with any other invasion procedure, flow-di-
rected catheterization can be associated with compli-
cations but probably in less than I% to 2% of all 
insertions.3 
I. Ventricular and atrial arrhythmias, including 
ventricular tachycardia and fibrillation. 
2. Pulmonary infarction 
3. Ruptured cordae tendenae of the tricuspid 
valve. 
4. Rupture of a pulmonary artery and/ or capillary 
with subsequent hemorrhage 
5. Infections 
6. Knotting of catheters. 
The Nurse's Role 
The critical care nurse plays an important and 
essential role during and following the catheteriza-
tion. It is his or her responsibility not only to set up 
and calibrate the transducers but also to assist during 
the actual catheterization. The nurse must be pro-
ficient in monitoring the electrocardiogram during 
catheter placement and inform the physician of any 
potentially serious arrhythmias. Additionally, he or 
she must be an expert in monitoring and reporting 
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the pulmonary artery and pulmonary wedge pr~s­
sures. Finally, the nurse must be acquainted with the 
problems associated with obtaining accurate pressure 
measurements and be alert to possible complications 
that can occur with the flow-directed catlieter. 
In summary, with the aid of the balloon-tipped 
flow-diteeted catheter, we are now able to measure 
pulmonary artery and pulmonary capillary wedge 
pressures at the bedside. The results obtained from 
pulmonary artery catheterization have added greatly 
to the management of the critical ill patient. 
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Intrapulmonary Lymph Node Presenting as a 
'Coin' Lesion: A Case Report 
SIBU P. SAHA, M .D . 
PORTER MA YO, M.D. 
Intrapulmonary lymph node seldom presents as 
a solitary pulmonary nodule. This rare clinical entity 
is reported in the following case: 
Case Report 
A 40-year-old woman was evaluated because of 
the radiological finding of a noncalcified, non-
cavitary, solitary, pulmonary nodule. She was asymp-
tomatic at the time of examination. The patient's past 
history included hiatal hernia, duodenal ulcer, and 
recurrent supraventricular tachycardia. She has ha-
bitually smoked one pack of cigarettes daily for 15 
years. The physical examination was unremarkable 
except for mlld obesity. 
A round density in the right infrahilar area was 
found in chest roentgenogram, which was not present 
in previous films. Tomographic examination showed 
a smooth mass without cavitation and calcification 
(Figure). 
Bronchoscopic examination was normal and the 
patient underwent exploratory right thoracotomy. A 
firm, smooth mass was located in the anteromedial 
segment of the right lower lobe. A vertical incision 
was made directly over the lesion to a depth of ap-
proximately 2 cm through the lung tissue. The ex-
posed nodule was completely excised and reported as 
benign intrapulmonary lymph node. The post-
operative course was uneventful. 
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Discussion 
An intrapulmonary lymph node large enough to 
present as a "coin" lesion on chest x-ray is rare. 
Steele' reported only four such cases in 887 resected 
solitary pulmonary nodules. Lymph nodes are nor-
mally . found around the main bronchi and its lobar 
branches, usually extending only as far as the third or 
fourth divisions. Only aggregations of lymphoid tis-
sue are found beyond this point. According to Trap-
nell,2 Mill er believed that the intrapulmonary lymph 
nodes developed in abnormal lung from lymphoid 
tissue. The lymphoid tissue in lungs wou.ld increase 
with age, probably in response to inhaled carbon 
particles or infections. Trapnell in his study of 92 
postmortem lungs found six cases of intrapulmonary . 
lymph node and concluded that "such nodes are not 
nearly so uncommon as is suggested by the litera-
ture." Greenberg3 reported a case of subpleural 
lymph node in 1961. This was a hyperplastic lymph 
node caused by anthracotic pa rticles. A similar case 
has been reported by Rosenthal and his associates.4 
Exploratory thoracotomy followed by resection 
continues to be the most commonly used method in 
the diagnosis and treatment of a solitary pulmonary 
nodule. 
Summary 
A case of intrapulmonary lymph node present-
ing as a solitary pulmonary nodule is presented with a 
brief discussion . 
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Figure-Tomogram of a noncavitary, noncalcified intrapulmonary mass. 
Acknowledgment: We thank Connie Powell for 
her assistance in the preparation of this manuscript. 
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Maxillary Periapical Actinomycosis: A Case 
with an Unusual Roentgenographic 
Appearance 
DANNY R. SAWYER, D.D.S., PH.D. 
Department of Oral Surgery and Pathology, Lagos University Teaching Hospital, C.M. UL. , Lagos, Nigeria 
DENNIS G. PAGE, D.D.S., M.S. 
Department of Oral Pathology, Medical College of Virginia, Richmond, Virginia 
Actinomycosis was once a fairly common dis-
ease and one that has a long history . "It was un-
doubtedly observed early in the 19th Century, as 
actinomycotic lesions were described erroneously in 
1826 by LeBlanc as osteosarcomas and later in the 
1800s Bollinger (1876) first recognized it as a specific 
entity which he named 'lumpy jaw.' " 1 The most fre-
quent clinical form of actinomycosis is the cervico-
facial type which is seen in 60% of reported cases, the 
other forms being abdominal (20% ), pulmonary 
(15%), and cutaneous (5%).2 Young adult males are 
most frequently affected with actinomycosis .3 The 
actinomycetes, the so-called "higher" bacteria, are 
among the more common microorganisms found 
within the oral cavity'; however, they seldom exist as 
pathogens within the oral cavity, and Goldstein et al 
(1972)5 report that there are fewer than 50 cases of 
actinomycosis of the maxilla reported in the English 
literature. Periapical actinomycosis is seen even less 
frequently . Browne and O'Riordan6 reported a case 
of periapical actinomycotic granuloma and found 
that only ten such cases were on record before 1966. 
In 1975 Samanta et aF reported that the analysis of 
cases reported subsequently to those of Browne and 
O'Riordan revealed only five additional cases in 
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which colonies of actinomycetes were demonstrated 
on histologic studies of the periapical tissue. 
The diagnosis of actinoniycosis may be accom-
plished by several means. While a direct smear of the 
pus and identification of the sulfur granules are sug-
gestive of actinomycosis , anaerobic culture or histo-
logic evidence, or both, are considered diagnostic. 
The roeiltgenographic appearance of cervicofacial ac-
tinomycosis is not diagnostic, although chronicity 
and a relative lack of bone reaction are suggestive.a 
The appearance may vary from one of lytic destruc-
tion without bone formation to one of a definite 
thickening and sclerosis.a The most common appear-
ance of maxillary actinomycosis is a localized radio-
lucent periapical or periodontal abscess in a healthy 
adult who shows no signs of systemic toxicity.• In 
distinction to mandibular actinomycosis, cutaneous 
fistulas or hard facial swellings are unusual in the 
maxillary form of the disease. Antral-facial fistulas as 
well as oral-antral fistulas have been noted from max-
illary molar extraction sites. Intraoral mucosa) drain-
age occurs much more frequently with maxillary acti-
nomycosis than with the mandibular form of the 
disease. Oral trauma or a preexisting condition is a 
common feature of maxillary actinomycosis. 
This paper describes a case of the rare form of 
maxillary periapical actinomycosis with a bizarre 
roentgenographic appearance. The clinical signs and 
symptoms along with the roentgenographic appear-
ance of this lesion were not suggestive of acti-
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Fig 1-Radiograph showing bizarre periapical lesion . Note 
"soapbubble" appearance. 
nomycosis and thus were not included within the 
clinical differential diagnosis . 
Case Report 
A 33-year-old white female consulted her private 
practitioner, and upon radiographic examination, a 
radiolucent lesion associated with the apex of the 
upper left first molar was discovered (Fig I). Ques-
tioning revealed that the lesion had been present for 
over three years during which ti me the patient had 
not sought treatment. Clinically, friable brownish tis-
sue with multiple root fragments was surgically re-
moved by excisional biopsy and sent to the labora-
tory for histologic examination . 
Histologic ·examination revealed a multi-
Z.'i">'· ?' I 
Fig 3-Histologic sect ion showing actinomycotic granule 
surrounded by sea of polymorphonuclear leukocytes. (H & 
E, 200 X ) 
sectioned soft tissue mass composed of gran-
ulomatous fibrous connective tissue containing areas 
of central abscess formation from which radiating 
hyphae-like structures showing the characteristic eo-
sinophilic " clubs" were seen (Fig 2). These "gran-
ules" appeared to be floating in a sea of polymorpho-
nuclear leukocytes associated with an occasional 
macrophage and multinucleated giant cell (Fig 3). On 
the surface of this lesion several organisms having 
budding yeast-like forms scattered along pseudo-
hyphae were noted (Fig 4). Pathologic diagnosis 
based on histologic examination with special stains 
was a mixed infection of actinomycosis and a superfi-
cial candidosis. 
Following surgical removal of the lesion and 
tt l 
Fig 2-Histologic section showing typical actinomycotic 
"granule." (Mallory's Gram method, 400X) 
Fig 4-Histologic section showing pseudohyphae of Can-
dida on surface of actinomycotic granule. (Mallory's Gram 
method, 400 X ) 
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Fig 5-Follow-up radiograph showing resolution and heal-
ing of site of localized lesion. 
histologic diagnosis of the tissue, the patient's local 
practitioner began treatment with Penicillin V-K, 250 
mg tablets four times per day for twenty days and 
nystatin (Mycostatin) (500,000 units), I tablet three 
times per day. Systemic involvement of the disease 
was ruled out by medical examination. One year fol-
lowing treatment, roentgenographs of the area 
showed complete resolution of the lesion (Fig 5). 
Discussion 
The unique feature of this case is the bizarre 
radiographic appearance of the lesion. In contrast to 
the normal localized radiolucent periapical lesion of 
maxillary peria,pical actinomycosis, this lesion ap-
peared radiographically as a multilocular lesion 
("soap bubble" appearance) more characteristic in 
this region of a giant cell granuloma, myxoma, or 
brown tumor of hyperparathyroidism. 
Clinicians often associate actinomycosis with the 
more florid soft-tissue cervicofacial type and this is 
obviously not always found owing to the localization 
of maxillary lesions which tend to remain asympto-
matic. 
In terms of treatment in maxillary periapical 
lesions, Stenhouse3 notes that there appears to be no 
need for recourse to prolonged antibiotic therapy 
whenever surgical intervention alone can totally erad-
icate the infected focus . This case substantiates this 
claim. 
Summary 
An unusual case of maxillary periapical acti-
nomycosis presenting with a bizarre roentgeno-
graphic appearance is presented. Local surgical eradi-
cation coupled with short-term drug therapy resulted 
in the complete resolution of the lesion. 
Acknowledgment: Dr. Tuggle assisted in the de-
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The Dental Health Status of Pre-Columbian 
Peruvians: A Study of Dental Caries, Missing 
Teeth, Attrition, Osteitis, Calculus, and Bone 
Loss 
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Prior to the recent reports of Sawyer et al1 and 
Elzay et al2 on the characteristics and dental health 
status of ancient Peruvian cultures, only Stewart3, 
Leigh4, and Goaz and Miller5 had reported on the 
dental morphology and pathology of the pre-Colum-
bian Peruvian Indians. The purpose of this study is to 
evaluate the dental health of these ancient peoples to 
further our understanding of the development of den-
tal diseases. This paper follows up and expands the 
report of Elzay et al2 to include another culture and 
Supported by a grant from the National Geographic Society 
and a NIDR-NIH Fellowship No. IF 32 DE 05091-01. 
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completely new specimens, with a look at primary 
dentitions not previously available for study. 
Materials and Methods 
The permanent maxillae from 115 individuals, 
and 113 permanent mandibles along with 46 individ-
ual primary maxillae and their primary mandibles, 
separated by cultural groups, were included in this 
survey. Only four specimens were found which had a 
mixed dentition and these were not included in this 
study. Thus, those maxillae and mandibles labeled 
permanent had only permanent dentitions and those 
labeled primary had only primary dentitions. All ex-
aminations were completed by gross examination of 
materials with dental probes and explorers under op-
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timal light. A dental radiographic unit was available 
and x-rays were used to confirm diagnoses. 
The only teeth counted as missing were those 
apparently lost prior to death as shown by osseous 
healing in the edentulous area. Third molars were 
considered congenitally absent if there was no evi-
dence of previous tooth loss and subsequent repair, 
or if they did not show on x-ray or were not grossly 
present. If the third molar crown appeared within the 
bone but had not completely erupted, the tooth was 
classified as either semi- or unerupted. 
Attrition or abrasion with no gross loss of crown 
enamel was scored as O; the tooth was scored as I if 
enamel loss on the cusp tips did not involve the 
grooves and fissures, as 2 if the enamel loss involved 
the grooves and fissures, and as 3 if the process elimi-
nated the grooves and fissures on the occlusal surface. 
This system differs from the Attrition Index of La-
velle6 only in omitting a fourth category for teeth 
having pulp exposure from attrition and in recording 
the highest score (most severe) noted on the specimen 
in lieu of individual scores for all teeth of the speci-
men. 
The incidence of dental caries was recorded in 
two ways. First, caries were recorded according to the 
DMFS (decayed, missing, filled surfaces) index. If a 
tooth had a carious lesion involving only one of its 
five surfaces, that is, mesial, distal, buccal, lingual 
and occlusal (incisal), it was scored as I. A missing 
tooth (antemortem) or one with all five surfaces 
carious received a score of 5. This system denotes 
severity of disease whereas reporting the percent of 
teeth affected reports only the caries rate. The second 
method of recording specimens was a modification of 
the DMFS index. While most teeth today are lost as a 
result of dental caries, teeth may have been lost in 
ancient times through trauma, periodontal disease, or 
pulpitis from severe attrition. Hardwick7 developed a 
method, attempting to correct this; however, it is 
more meaningful to express caries incidence by omit-
ting missing teeth. Hence, dental caries involvement 
is expressed as OS (decayed tooth surfaces) per tooth 
and jaw (specimen). 
The condition of osteitis was recorded as present 
or absent only. Gross evidence of either bone destruc-
tion and/or proliferation with or without a fistulous 
tract was recorded as osteitis . 
The degree of calculus formation was indicated 
as light if less than I mm of calculus was deposited on 
the lingual surfaces of the anterior teeth, moderate if 
concomitant deposition around posterior teeth was 
less than I mm, and heavy if calculus deposition on 
anterior or posterior teeth exceeded I mm. 
Bone loss was recorded on a scale of 0 for no 
gross evidence, 1 for interdental bone loss between 
adjacent teeth, 2 for bone loss down to the bifurca-
tion area of the roots, and 3 for bone loss beyond the 
bifurcation area. In any one jaw specimen only the 
most severe manifestation of bone loss was recorded. 
Results 
The results for the permanent dentitions and 
jaws are tabulated in Tables 1, 2 and 3, while the 
results for the primary dentitions and jaws are tabu-
lated in Tables 4, 5 and 6. Individuals from the lea 
culture and the Paracas culture (Table 1) exhibited 
the highest incidence of missing teeth in the maxillary 
arch, those from the Colonial culture showed the 
highest incidence of missing teeth in the mandible. 
The N azca culture Indians followed by those of the 
H uari culture showed the fewest missing teeth in both 
arches. The lea and Paracas culture Indians showed 
the highest incidence of missing first, second, and 
third molars in the maxillary arch while the Paracas 
and Colonial culture Indians had the highest in-
cidence of missing first, second, and third mandibular 
molars. Individuals from the Paracas culture fol-
lowed by those from the Colonial culture showed the 
highest incidence of congenitally missing third molars 
in both arches. 
The Paracas, lea and Colonial Indians had the 
highest incidence of dental caries in both arches in the 
permanent dentitions (Table 2). Nazca culture in-
dians showed a low incidence of dental caries while 
the Incas showed the lowest of all. In individuals witfi 
the permanent dentitions, those from the Nazca and 
Inca cultures had the highest incidence of osteitis in 
the two arches. The Paracas, lea and Colonial In-
dians had the highest degree of moderate and heavy 
calculus. While there is little difference in the degree 
of bone loss in the six cultures, the Paracas Indians 
showed a somewhat higher degree of loss. 
With regard to primary arches and dentitions, 
the only antemortem tooth losses were one tooth in 
the maxillae in the Colonial individuals and two teeth 
lost from the mandibular arches of the those from the 
lea culture (Table 4). No first or second molars of 
either arch were lost in these specimens and there 
were no congenitally missing teeth. As with the per-
manent dentitions, the Paracas, lea and Colonial In-
dians had the highest incidence of dental caries in 
both arches (Table 5). Individuals from these three 
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TABLE 1 
Frequency of Missing or Unerupted Teeth in the Pernianent Dentitions 
CULTURE N NTP 
Paracas 
maxillary 46 736 
mandibular 31 496 
Nazca 
maxillary 9 144 
mandibular 20 320 
Huaii 
maxillary 13 208 
mandibular 14 224 
lea 
maxillary 24 384 
mandibular 25 400 
Inca 
maxillary 20 320 
mandibular 19 304 
Colonial 
maxillary 20 320 
mandibular 21 336 
Average 
maxillary 22.0 352.0 
mandibular 21.7 346.7 
N = number of jaw specimens 
NTP = number of teeth possible 
X = mean 
TEETH LOST X TEETH 
LOST PER 
NUMBER % JAW 
IOI 13 .7 2.2 
64 12.9 2.1 
10 6.9 I. I 
30 9.4 1.5 
19 9.1 1.5 
23 10.3 1.6 
56 14.6 2.3 
52 13.0 2.1 
42 13.1 2.1 
42 13 .8 2.2 
33 10.3 1.7 
55 16.4 2.6 
43.5 11.28 1.82 
44.3 12.63 2.02 
cultures also showed (Table 6) the highest incidence 
of osteitis and the highest degree of moderate and 
heavy calculus. The Paracas culture Indians showed a 
slightly higher degree of bone loss in the arch than the 
other cultures, but this difference is not significant. 
Discussion 
The results indicate that in the permanent denti-
tions the Paracas, lea and Colonial individuals have 
the highest incidence of missing antemortem teeth 
while in the primary dentitions only the lea and Colo-
nial cultures have specimens showing tooth loss . The 
Nazca and Huari permanent dentitions exhibit the 
lowest incidence of antemortem tooth loss . These 
findings parallel dental caries incidence, as the Para-
cas, lea and Colonial Indians have the highest in-
cidence of dental caries in both the permanent and 
primary dentitions. The incidence of antemortem 
tooth loss has been reported to decline spectacularly 
with the transition to an agricultural society, from 
M3 
% % MOLAR I MOLAR 2 
CoNGEN- WITH SEMI- % % 
% !TALLY OR 
NTP MISSING MISSI NG UN ERUPTED LACKING LACKING 
92 18 .5 5.5 17.4 19.6 18.5 
62 19.4 4.9 24.2 35.5 37.1 
18 I I. I 0.0 22.2 I I. I 16.7 
40 12.5 0.0 10.0 15.0 22.5 
26 11.5 0.0 23.1 19.2 15.4 
28 7.1 0.0 3.6 28.6 21.4 
48 18.8 2.1 27.1 20.8 33.3 
50 16.0 4.0 24.0 34.0 32.0 
40 12.5 0.0 57.7 2.5 2.5 
38 10.5 0.0 47.4 5.3 5.3 
40 10.0 5.0 5.0 17.5 7.5 
42 19.0 4.8 7.1 47.6 35 .7 
44.0 13.73 2.10 25.38 15.12 15.65 
43.3 14.08 2."28 19.38 27.67 25.68 
41.6% loss in early hunting and gathering economies 
to 6.2% in the most recent phases.8These pre-Colum-
bian cultures were primarily agricultural societies. 
Average tooth loss in the permanent dentitions was 
11.3% in the maxillary arch and 12.6% in the man-
dibular arch. Iri our earlier study2 consisting of 101 
mandibles, an 18.6% antemortem loss was found. The 
tabulated findings on antemortem tooth loss in ten 
prehistoric adult populations show a 19.9% loss for 
Gran Canaria.9 The Inca individuals showed the 
highest incidence of semi- or unerupted third molars. 
This group also had low scores for caries, bone loss, 
and calculus, suggesting that although the sample 
was an adult population, it was a younger age group 
than the other cultures. (This was later confirmed by 
age analysis.) 
The Paracas, Colonial and lea Indians showed 
evidence of congenitally missing third molars. The 
Paracas individuals showed the highest incidence of 
congenitally missing third molars in both arches, 
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beirig 5.~% in the maxillae and 4.9% in the mandible. 
The Nazca, Huari and Inca Indians showed no speci-
men with congenitally missing teeth among those 
stud\~d. The average for all six cultures was 2.1 o/o for 
ihe rµaxillae third molars and 2.3% for the mandibu-
lar third molars. 
While at least one of the cultures consisted of 
young adults, the incidence of third molar hypo-
dontia was 15.8% (including those that were con-
genitally missing) for the maxillary arches and 16.4% 
(including the congenitally missing) for the mandibu-
lar arches. Carbonell'0 reported a 2.6% incidence of 
third tnolar hypodontia (mandibles only) in the Kish 
of Mespotania (3000 B.C.) while Crispim et al 11 re-
ported 8% per quadrant and 2% for all four third 
molars in a trihybrid Brazilian population. Niswan-
der12 reported a 30.5% incidence of one or more miss-
ing third molars in the Xavante Indians of Brazil, and 
Dahlberg13 indicated that Mongoloid people have a 
higher percentage of agenesis of third molars than do 
other groups. Our earlier data2 showed a third molar 
hypodontia of 3.6% in IOI mandibles. The present 
data more clearly confii".nis what one would expect in 
a population of Mongoloid background. An obvious 
difficulty in comparison of available data is the lack 
of uniformity in reporting results . 
Our findings on attrition indicate that the six 
pre-Columbian cultures had moderate attrition and 
no resulting pulp exposures. Occlusal wear pattern 
was not noticeably oblique as noted in cultt1r~s where 
teeth are used to strip husk or bark from a food 
sourc~. It would appear that the cultures shared a 
similar diet in terms of consistency and/ or prepara-
tion. Previous reports3·4 ori pre-Columbian Peruvians 
also found no severe attrition or pulp involvement. 
Similarly, Carbonell 14 found no pulp involvement 
from attrition in ancient Mesopotamians. Although 
the data on partially erupted third molars suggest 
that the Inca specimens are of a younger age, these 
individuals still had attrition effects similar to the 
specimens of the other cultures. 
Results of dental caries have meaning only when 
comparisons are made among the cultures observed. 
While lower age may cause the low caries in the Inca 
TABLE 2 
Frequency and Severity of Attrition and Dental Caries in the Permanent Dentitions 
X SCORE CARIES BASED ON OMFS CARI ES BASED ON OS 
OF ATTRITION 
CULTUR E N 0, I, 2, 3 TNT X OMFS/ rnoTH X OMFS/ JAW x OS/ TOOTH x OS/ JAW 
Paracas 
m~x ill ary 45 1.8 434 2.23 19.20 1.08 8.02 
mandibular 30 1.9 362 2.30 22.90 1.16 11.50 
Nazca 
maxillary 9 2.1 102 1.02 11.56 0.43 4.89 
mandibular 20 2.2 264 1.03 13.65 0.47 6.15 
Huari 
maxill ary 13 1.6 142 1.37 15.00 0.70 7.69 
mandibular 14 1.9 174 1.25 10.79 0.59 7.36 
ica 
maxillary 24 1.9 294 1.96 24.04 1.01 12.38 
mandibular 25 2.2 296 1.97 21.72 1.01 11.32 
Inca 
maxillary 20 1.8 316 0.22 3.55 o.m 0.55 
mandibular 19 1.9 302 0.24 3.74 0.04 0.58 
Coloriial 
maxiilary 20 2.1 295 1.66 24.45 1.15 16.95 
manaibular 21 2.1 306 1.82 26.48 0.87 12.67 
Average 
maxilhiry 15.2 1.88 263.8 1.410 16.300 0.733 8.413 
mandibular 21.5 2.03 284.0 1.435 16.547 0.690 8.263 
N = number of jaw specimens 
TNT = total number of teeth 
X = mean 
OMFS = decayed , missing, filled tooth surfaces 
OS = decayed surfaces 
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TABLE 3 
Frequency and Severity of Osteitis, Calculus and Bone Loss in the Permanent Dentitions 
0STEIT!S CALCU LUS % AFF ECTED BONE Loss 
CULTURE N % AFFECTED N LIGHT MODERATE HEAVY N X SCORE 0, 1,2,3 
Paracas 
maxi llary 46 32.6 45 30.0 50.0 20.0 46 1.8 
mandibular 31 38 .7 30 23 .3 50.0 26.7 31 2.0 
Nazca 
maxi llary 9 44.4 9 87.5 12.5 0.0 9 1.7 
mandibular 20 45.0 20 83.3 5.6 I I.I 20 1. 5 
Huari 
maxi llary 13 15 .3 13 83.4 16.6 0.0 13 I. I 
mandibul ar 14 14.2 14 83.4 8.3 8.3 14 1.2 
lea 
maxi llary 24 16.7 24 33 .3 44.5 22.2 24 l.J 
mandibular 25 20.0 25 35 .0 40.0 25.0 25 1.3 
Inca 
maxillary 20 33 .0 20 33. .3 66.7 0.0 20 1.2 
mandibular 19 50.0 19 50.0 50.0 0.0 19 1.3 
Colonial 
maxillary 20 20.Q 20 40.0 40.0 20.0 20 1.4 
mandibular 21 23.8 21 57.0 21.5 21.5 21 1.3 
Average 
maxi llary 22.0 27.00 15.2 5 1.25 38 .38 10 .37 22.0 1.42 
mand ibular 21.7 31.95 2 1. 5 55 .34 29.23 15.43 21.7 1.43 
N = number of jaw specimens 
X = mean 
TABLE 4 
Frequency of Missing or Unerupted Teeth in the Primary Dentitions 
TEETH LOST % MOLAR I MOLAK 2 
X TEETH CONGENITALLY 
CULTURE N NTP NUMB ER % LOST PER JAW MISSING LACKI NG LACKING 
Paracas 
maxi ll ary 9 90 0 0.0 0.0 0.0 0.0 Q.O 
mandibular 6 60 0 0.0 0 .0 0.0 0.0 0.0 
Nazca 
maxillary 2 20 0 0.0 0 .0 0.0 0 .0 0.0 
mandiqular 2 20 0 0.0 0.0 0.0 0.0 0.0 
Huari 
maxillary 4 40 0 0.0 0.0 0.0 0.0 0.0 
mandibu lar 3 30 0 0.0 0.0 0.0 0.0 o.6 
(ca 
maxillary 14 140 0 0.0 0 .0 0.0 0.0 0.0 
mandibular 15 150 2 1.3 0. 13 0.0 0.0 0.0 
Inca 
maxillary 2 20 0 0.0 0.0 0.0 0.0 0.0 
mandibu lar 3 30 0 0 .0 0.0 0.0 0.0 0.0 
Colonial 
maxillary 15 150 I 0 .7 0.06 0.0 0.0 o:o 
mandibu lar 16 160 0 0 .0 0.0 0.0 0.0 9.0 
Average 
maxillary 7.7 76.7 0.16 0 .12 0.0 1 0.0 0.0 0.0 
mandibular 7.5 75 .0 0.33 0.22 0.02 o.6 0 .0 0.0 
N = number of jaw specimens 
NTP = number of teeth possible 
X = mean 
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TABLE 5 
Frequency and Severity of Attrition and Dental Caries in the Primary Dentitions 
CULTURE N 
Paracas 
maxillary 9 
mandibular 6 
Nazca 
maxillary 2 
mandibular 
Huari 
maxillary 4 
mandibular 3 
lea 
maxillary 14 
mandibular 15 
Inca 
maxillary 2 
mandibular 3 
Colonial 
maxillary 15 
mandibular 16 
Average 
maxillary 7.7 
mandibular 8.6 
N = number of jaw specimens 
TNT = total number of teeth 
X = mean 
X SCORE 
OF ATTRITION 
0, 1,2,3 
1.5 
1.3 
1.3 
1.5 
1.6 
1.7 
1.6 
1.0 
0.8 
1.2 
I. I 
1.37 
1.28 
OMFS = decayed, missing, filled tooth surfaces 
OS = decayed surfaces 
TNT 
76 
54 
19 
34 
24 
105 
123 
JO 
28 
115 
128 
59.8 
71.4 
Indians, the reasons for different caries incidence in 
the remaining groups are not as obvious. The three 
groups scoring high on caries also scored highest in 
calculus involvement. The Paracas, lea and Colonial 
individuals who had the highest caries incidence were 
all members of "coastal" as opposed to "inland" 
cultures. Something in the diet or water of the "in-
land" people, such as fluoride, could have protected 
them against caries. Further investigation on fluoride 
content of bones and teeth should shed some light on 
this relationship. The reason for a lower incidence of 
caries in the Nazca individuals, also a "coastal" 
group, is not readily apparent. 
The maxillae are more frequently involved with 
caries than the mandible. 15 In the present study this 
was noted using both the incidence of caries based on 
DMFS and on OS in primary dentitions. The max-
illae were shown to be more frequently involved with 
caries using the DS index in the permanent denti-
tions, but because of the large number of mi~sing 
teeth (antemortem) in the mandibles of the per-
CARIES BASED ON OMFS CARIES BASED ON OS 
X OMFS/ TOOTH X OMFS/ JAW x OS / TOOTH x OS/ JAW 
0.49 4.1 0.49 4.1 
0.35 3.2 0.35 3.6 
0.21 2.0 0.21 2.0 
0.47 4.0 0.47 4.0 
0.17 1.3 0.17 1.3 
0.47 3.5 0.47 3.5 
0.33 2.7 0.25 2.1 
0.10 0.5 0. JO 0.5 
0.00 0.0 0.00 0.0 
0.55 4.2 0.50 3.9 
0.36 2.9 0.36 2.9 
0.382 3.05 0.373 3.00 
0.242 2.02 0.226 1.98 
manent dentitions, the DMFS showed the incidence 
of caries to be about equal in the two arches. Because 
of the method of scoring using the DMFS index, this 
can be considered a misleading value and again the 
maxillae showed a higher incidence of caries. In this 
study, using optimal gross examination coupled with 
roentgenographic analysis, 26.7% of the individuals 
with primary dentitions and 85.2% of the individuals 
with permanent dentitions had one or more carious 
lesions. In our earlier study2 70% of the permanent 
mandibles had one or more carious lesions. Leigh4 
reported a 35% incidence in specimens having both 
jaws. Although the reason is still not evident, the high 
incidence of caries has now been shown to be consis-
tent in our two studies and in fact increased because 
of the inclusion in this present study of maxillae 
having a higher incidence of dental caries. The caries 
incidence in the combined adult population in the 
United States as of 1962 was 20.4 DMFS teeth per 
person. 16 The overall average of DMFS per specimen 
in our earlier pre-Columbian study2 was 13.76 in IOI 
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TABLE 6 
Frequency and Severity of Osteitis, Calculus and Bone Loss in the Primary Dentitions 
0STEITIS 
CULTURE N 
Paracas 
maxillary 9 
mandibular 6 
Nazca 
maxillary 2 
mandibular 2 
Huari 
maxillary 4 
mandibular 3 
lea 
maxillary 14 
mandibular 15 
Inca 
maxillary 2 
mandibular 3 
Colonial 
maxillary 15 
mandibular 16 
Average 
maxillary 7.7 
mandibular 7.5 
N = number of jaw specimens 
X = mean 
% AFFECTED 
I I. I 
16.7 
0.0 
0.0 
0.0 
0.0 
7.1 
6.7 
0.0 
0.0 
6.7 
12.5 
4.15 
5.98 
N 
9 
6 
2 
4 
3 
14 
15 
2 
3 
15 
16 
7.7 
8.6 
permanent mandibles. In the present study the aver-
age DMFS was 16.3 per maxillary specimen and 16.5 
per mandibular specimen. The higher DMFS per 
specimen in the present study as compared to our 
earlier work is no doubt related to the use of the x-ray 
unit. While these figures do not correspond exactly 
with those in the United States as of 1962, they are 
similar, as to incidence of caries, to the present study. 
Caries data on present day Peruvians are not avail-
able for comparison. 
Osteitis was noted in all six cultures. The Nazca 
and Inca showed the highest incidence in the arches 
with permanent dentitions while the Paracas, lea and 
Colonial individuals had the highest incidence in the 
primary. This finding paralleled the findings on the 
mean number of missing antemortem teeth while cal-
culus accumulation appeared to relate directly to 
caries incidence. 
The amount of alveolar bone loss was moderate 
among individuals from all cultures with those from 
the Paracas culture leading the way. Bone loss did not 
correlate directly with calculus or caries scores. It is 
plausible that a less refined and abrasive diet caused 
both moderate attrition and alveolar bone loss in all 
cultures irrespective of age. 
CALCULUS o/o AFFECTED BONE Loss 
LIGHT MODERATE HEAVY N X SCORE 0, I ,2 ,3 
37.5 50.0 12.5 9 1.5 
40.0 40.0 20.0 6 1.7 
50.0 50.0 0.0 2 1.5 
2 1.5 
66.7 33.3 0.0 4 1.0 
50.0 50.0 0.0 3 1.2 
46.2 46.2 7.6 14 1.2 
50.0 35.7 14.3 15 I.I 
50.0 50.0 0.0 2 1.2 
66.7 33.3 0.0 1.3 
6.7 93 .3 0.0 15 1.3 
12.5 87.5 0.0 16 1.4 
42.85 53 .80 3.35 7.7 1.27 
43.84 49.30 6.86 7.5 1.37 
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A normal reaction to emotional stress is a marked 
increase in both the strength and frequency of wave-like 
contractions of colonic motility.1 However, in the patient 
with irritable bowel syndrome, this psychovisceral 
reaction is of greater intensity and duration than normal.2 
The result can be G.I. spasm. 
When spasm and pain associated with irritable bowel 
syndrome call for treatment beyond your counseling and 
reassurance, Donnatal may prove to be a helpful adjunct. 
The smooth central sedation and prompt peripheral 
antispasmodic/ anticholinergic action of Don natal may 
provide this symptomatic relief necessary to help calm 
the waves ... and quell the spasm. 
References: 1. Almy, T.P., Kern, F. , and Tulin, M.: Alterations in colonic function in 
man under stress. II: Experimental production of sigmoid spasm in healthy persons. 
Gastroenterology 12(3):425-436, 1949. 2. Almy, T.P. , Hinkle, L.E. , Berle, B., et al. : 
Alterations in colonic function in man under stress. Ill: Experimental production of 
sigmoid spasm in patients with spastic constipation. Gastroenterology 
12(3):437-449, 1949. 
'''Indications: Based on a review of this drug by the NAS/ NRC and / or 
other information, FDA has classified the following indications as 
possibly effective: adjunctive therapy in the treatment of peptic ulcer; 
the treatment of the irritable bowel syndrome (irritable colon, spastic 
colon, mucous colitis) and acute enterocolitis. 
Final classification of the less-than-effective indications requires 
further investigation . 
Contraindicated in patients with glaucoma, renal or hepatic 
disease, obstructive uropathy (for example, bladder neck obstruction 
due to prostatic hypertrophy), or a hypersensitivity to any of the 
ingredients. Blurred vision, dry mouth, difficult urination, and flushing or 
dryness of the skin may occur at higher dosage levels, rarely at the 
usual dosage. 
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